Panacea Biotec Limited (PANACEABIO.BO)
INR 522.95
(5.0%)
INR 522.95
(5.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.35 Billion INR | -19.86% |
| 2022 | 1.78 Billion INR | -50.4% |
| 2021 | 3.59 Billion INR | -7.68% |
| 2020 | 3.89 Billion INR | 7.31% |
| 2019 | 3.62 Billion INR | 45.26% |
| 2018 | 2.49 Billion INR | -33.55% |
| 2017 | 3.75 Billion INR | 2.93% |
| 2016 | 3.64 Billion INR | -16.54% |
| 2015 | 4.37 Billion INR | 7.44% |
| 2014 | 4.06 Billion INR | 44.52% |
| 2013 | 2.81 Billion INR | -18.4% |
| 2012 | 3.45 Billion INR | -4.81% |
| 2011 | 3.62 Billion INR | -37.66% |
| 2010 | 5.81 Billion INR | 35.57% |
| 2009 | 4.28 Billion INR | -48.53% |
| 2008 | 8.33 Billion INR | -0.99% |
| 2007 | 8.41 Billion INR | 1.42% |
| 2006 | 8.3 Billion INR | 53.53% |
| 2005 | 5.4 Billion INR | 49.08% |
| 2004 | 3.62 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 277.7 Million INR | -29.64% |
| 2023 Q3 | 831.8 Million INR | -1.95% |
| 2023 Q2 | 848.3 Million INR | 14.13% |
| 2023 Q1 | 743.3 Million INR | 75.63% |
| 2023 FY | 1.42 Billion INR | -19.86% |
| 2023 Q4 | 394.7 Million INR | -52.55% |
| 2022 Q2 | 686.7 Million INR | 27568.0% |
| 2022 FY | 1.78 Billion INR | -50.4% |
| 2022 Q4 | 423.21 Million INR | -37.23% |
| 2022 Q3 | 674.2 Million INR | -1.82% |
| 2022 Q1 | -2.5 Million INR | -100.79% |
| 2021 FY | 3.59 Billion INR | -7.68% |
| 2021 Q3 | 1.09 Billion INR | -14.81% |
| 2021 Q2 | 1.28 Billion INR | 42.83% |
| 2021 Q1 | 898.2 Million INR | 14.67% |
| 2021 Q4 | 318.16 Million INR | -70.89% |
| 2020 Q4 | 783.26 Million INR | -21.08% |
| 2020 FY | 3.89 Billion INR | 7.31% |
| 2020 Q1 | 933.2 Million INR | 52.6% |
| 2020 Q2 | 1.18 Billion INR | 26.68% |
| 2020 Q3 | 992.5 Million INR | -16.05% |
| 2019 Q4 | 611.52 Million INR | -47.04% |
| 2019 Q2 | 882.9 Million INR | -9.64% |
| 2019 FY | 3.62 Billion INR | 45.26% |
| 2019 Q3 | 1.15 Billion INR | 30.77% |
| 2019 Q1 | 977.1 Million INR | 652.37% |
| 2018 Q2 | 767.9 Million INR | 2.65% |
| 2018 FY | 2.49 Billion INR | -33.55% |
| 2018 Q4 | 129.87 Million INR | -84.73% |
| 2018 Q3 | 850.4 Million INR | 10.74% |
| 2018 Q1 | 748.1 Million INR | 0.0% |
| 2017 FY | 3.75 Billion INR | 2.93% |
| 2016 FY | 3.64 Billion INR | -16.54% |
| 2015 FY | 4.37 Billion INR | 7.44% |
| 2014 FY | 4.06 Billion INR | 44.52% |
| 2013 FY | 2.81 Billion INR | -18.4% |
| 2012 FY | 3.45 Billion INR | -4.81% |
| 2011 FY | 3.62 Billion INR | -37.66% |
| 2010 FY | 5.81 Billion INR | 35.57% |
| 2009 FY | 4.28 Billion INR | -48.53% |
| 2008 FY | 8.33 Billion INR | -0.99% |
| 2007 FY | 8.41 Billion INR | 1.42% |
| 2006 FY | 8.3 Billion INR | 53.53% |
| 2005 FY | 5.4 Billion INR | 49.08% |
| 2004 FY | 3.62 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.46 Million INR | -12855.645% |
| Biocon Limited | 91.73 Billion INR | 98.523% |
| Blue Jet Healthcare Limited | 3.15 Billion INR | 57.1% |
| Concord Biotech Limited | 6.11 Billion INR | 77.822% |
| Dishman Carbogen Amcis Limited | 4.9 Billion INR | 72.362% |
| FERMENTA BIOTECH LIMITED | 1.82 Billion INR | 25.622% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | -82001.469% |
| Lyka Labs Limited | 145.95 Million INR | -828.586% |
| SAMSRITA LABS LIMITED | -1.28 Million INR | 105728.687% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 329.57 Million INR | -311.222% |
| Supriya Lifescience Limited | 2.65 Billion INR | 48.892% |
| Syngene International Limited | 12.43 Billion INR | 89.104% |
| TAKE Solutions Limited | 183.42 Million INR | -638.9% |
| Titan Biotech Limited | 884.66 Million INR | -53.199% |
| Transgene Biotek Limited | -1.69 Million INR | 80199.882% |
| Vanta Bioscience Limited | 7.12 Million INR | -18934.972% |